Targeting hypoxia-inducible factor-1 alpha suppresses Helicobacter pylori-induced gastric injury via attenuation of both cag-mediated microbial virulence and proinflammatory host responses

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–13. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Sci. 2000;287:1497–1500. doi:10.1126/science.287.5457.1497.
   PubMed Web of Science ®Google Scholar
• Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Sci. 2003;300(5624):1430–1434. doi:10.1126/science.1081919.
   PubMed Web of Science ®Google Scholar
• Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA. 2005;102:10646–10651. doi:10.1073/pnas.0504927102.
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest. 2001;107(7):767–773. doi:10.1172/JCI12672.
   PubMed Web of Science ®Google Scholar
• Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC, et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest. 2013;123:479–492. doi:10.1172/JCI64373.
   PubMed Web of Science ®Google Scholar
• Noto JM, Piazuelo MB, Shah SC, Romero-Gallo J, Hart JL, Di C, Carmichael JD, Delgado AG, Halvorson AE, Greevy RA, et al. Iron deficiency linked to altered bile acid metabolism promotes Helicobacter pylori-induced inflammation-driven gastric carcinogenesis. J Clin Invest. 2022;132:e147822. doi:10.1172/JCI147822.
   PubMed Web of Science ®Google Scholar
• Torres J, Correa P, Ferreccio C, Hernandez-Suarez G, Herrero R, Cavazza-Porro M, Dominguez R, Morgan D. Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America. Cancer Causes Control. 2013;24(2):249–256. doi:10.1007/s10552-012-0114-8.
   PubMed Web of Science ®Google Scholar
• Hirota K. An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs). Free Radic Biol Med. 2019;133:118–129. doi:10.1016/j.freeradbiomed.2018.07.018.
   PubMed Web of Science ®Google Scholar
• Park JH, Kim TY, Jong HS, Kim TY, Chun YS, Park JW, Lee CT, Jung HC, Kim NK, Bang YJ. Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells. Clin Cancer Res. 2003;9:433–440.
   PubMed Web of Science ®Google Scholar
• McGettrick AF, O’Neill LAJ. The role of HIF in immunity and inflammation. Cell Metab. 2020;32(4):524–536. doi:10.1016/j.cmet.2020.08.002.
   PubMed Web of Science ®Google Scholar
• Lin S, Ma R, Zheng XY, Yu H, Liang X, Lin H, Cai XJ. Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1alpha as a prognostic role in gastric cancer. World J Gastroenterol. 2014;20:1107–1113. doi:10.3748/wjg.v20.i4.1107.
   PubMed Web of Science ®Google Scholar
• Cowman SJ, Koh MY. Revisiting the HIF switch in the tumor and its immune microenvironment. Trends Cancer. 2022;8(1):28–42. doi:10.1016/j.trecan.2021.10.004.
   PubMed Web of Science ®Google Scholar
• Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, Brown C, Haenszel W. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst. 1976;57:1027–1035. doi:10.1093/jnci/57.5.1027.
   PubMedGoogle Scholar
• Cuello C, Correa P, Haenszel W, Gordillo G, Brown C, Archer M, Tannenbaum S. Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst. 1976;57(5):1015–1020. doi:10.1093/jnci/57.5.1015.
   PubMed Web of Science ®Google Scholar
• de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R, Bravo LE, Sicinschi LA, Delgado AG, Mera RM, et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut. 2011;60:1189–1195. doi:10.1136/gut.2010.234468.
   PubMed Web of Science ®Google Scholar
• Strowitzki MJ, Kimmer G, Wehrmann J, Ritter AS, Radhakrishnan P, Opitz VM, Tuffs C, Biller M, Kugler J, Keppler U, et al. Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses. JCI Insight. 2021;6(8):e13919. doi:10.1172/jci.insight.139191.
   Web of Science ®Google Scholar
• Chen MH, Wang YH, Sun BJ, Yu LM, Chen QQ, Han XX, Liu YH. HIF-1alpha activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization. Int Immunopharmacol. 2021;99:107901. doi:10.1016/j.intimp.2021.107901.
   PubMed Web of Science ®Google Scholar
• Hams E, Saunders SP, Cummins EP, O’Connor A, Tambuwala MT, Gallagher WM, Byrne A, Campos-Torres A, Moynagh PM, Jobin C, et al. The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells. Shock. 2011;36(3):295–302. doi:10.1097/SHK.0b013e318225ad7e.
   PubMed Web of Science ®Google Scholar
• Roy S, Rizvi ZA, Clarke AJ, Macdonald F, Pandey A, Zaiss DMW, Simon AK, Awasthi A. EGFR-HIF1alpha signaling positively regulates the differentiation of IL-9 producing T helper cells. Nat Commun. 2021;12:3182. doi:10.1038/s41467-021-23042-x.
   PubMed Web of Science ®Google Scholar
• Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, Sun J, Pan F, Zhou J, Zhang W, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457. doi:10.1038/s41467-020-18262-6.
   PubMed Web of Science ®Google Scholar
• Fachi JL, Pral LP, Dos Santos JAC, Codo AC, de Oliveira S, Felipe JS, Zambom FFF, Camara NOS, Vieira P, Colonna M, et al. Hypoxia enhances ILC3 responses through HIF-1alpha-dependent mechanism. Mucosal Immunol. 2021;14:828–841. doi:10.1038/s41385-020-00371-6.
   PubMed Web of Science ®Google Scholar
• Li M, Li G, Yang X, Yin W, Lv G, Wang S. HIF in gastric cancer: regulation and therapeutic target. Molecules. 2022;27(15):4893. doi:10.3390/molecules27154893.
   PubMed Web of Science ®Google Scholar
• Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol. 2003;23:359–369. doi:10.1128/MCB.23.1.359-369.2003.
   PubMed Web of Science ®Google Scholar
• Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004;23:1949–1956. doi:10.1038/sj.emboj.7600196.
   PubMed Web of Science ®Google Scholar
• Hubbi ME, Kshitiz Gilkes DM, Rey S, Wong CC, Luo W, Kim DH, Dang CV, Levchenko A, Semenza GL, Semenza GL. A nontranscriptional role for HIF-1α as a direct inhibitor of DNA replication. Sci Signal. 2013;6:ra10. doi:10.1126/scisignal.2003417.
   PubMed Web of Science ®Google Scholar
• Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, Taylor CT. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology. 2008;134:156–165. doi:10.1053/j.gastro.2007.10.012.
   PubMed Web of Science ®Google Scholar
• Hirota SA, Fines K, Ng J, Traboulsi D, Lee J, Ihara E, Li Y, Willmore WG, Chung D, Scully MM, et al. Hypoxia-inducible factor signaling provides protection in clostridium difficile-induced intestinal injury. Gastroenterology. 2010;139:259–269 e253. doi:10.1053/j.gastro.2010.03.045.
   PubMed Web of Science ®Google Scholar
• Schaible B, McClean S, Selfridge A, Broquet A, Asehnoune K, Taylor CT, Schaffer K, Karhausen J. Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa. PLoS One. 2013;8(2):e56491. doi:10.1371/journal.pone.0056491.
   PubMed Web of Science ®Google Scholar
• Lei X, Teng W, Fan Y, Zhu Y, Yao L, Li Y, Zhu S, Pileggi M. The protective effects of HIF-1α activation on sepsis induced intestinal mucosal barrier injury in rats model of sepsis. PLoS One. 2022;17:e0268445. doi:10.1371/journal.pone.0268445.
   PubMed Web of Science ®Google Scholar
• Kim YI, Yi EJ, Kim YD, Lee AR, Chung J, Ha HC, Cho JM, Kim SR, Ko HJ, Cheon JH, et al. Local stabilization of hypoxia-inducible factor-1alpha controls intestinal inflammation via enhanced gut barrier function and immune regulation. Front Immunol. 2020;11:609689. doi:10.3389/fimmu.2020.609689.
   PubMed Web of Science ®Google Scholar
• Harnoss JM, Gebhardt JM, Radhakrishnan P, Leowardi C, Burmeister J, Halligan DN, Yuan S, Kennel KB, Strowitzki MJ, Schaible A, et al. Prolyl hydroxylase inhibition mitigates pouchitis. Inflamm Bowel Dis. 2020;26:192–205. doi:10.1093/ibd/izz218.
   PubMed Web of Science ®Google Scholar
• Cane G, Ginouves A, Marchetti S, Busca R, Pouyssegur J, Berra E, Hofman P, Vouret-Craviari V. HIF-1alpha mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adhering E. coli and promotes EMT-like behaviour. Cell Microbiol. 2010;12:640–653. doi:10.1111/j.1462-5822.2009.01422.x.
   PubMed Web of Science ®Google Scholar
• Kempf VA, Lebiedziejewski M, Alitalo K, Walzlein JH, Ehehalt U, Fiebig J, Huber S, Schutt B, Sander CA, Muller S, et al. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation. 2005;111:1054–1062. doi:10.1161/01.CIR.0000155608.07691.B7.
   PubMed Web of Science ®Google Scholar
• Patel NJ, Zaborina O, Wu L, Wang Y, Wolfgeher DJ, Valuckaite V, Ciancio MJ, Kohler JE, Shevchenko O, Colgan SP, et al. Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am J Physiol Gastrointest Liver Physiol. 2007;292:G134–142. doi:10.1152/ajpgi.00276.2006.
   PubMed Web of Science ®Google Scholar
• Rupp J, Gieffers J, Klinger M, van Zandbergen G, Wrase R, Maass M, Solbach W, Deiwick J, Hellwig-Burgel T. Chlamydia pneumoniae directly interferes with HIF-1alpha stabilization in human host cells. Cell Microbiol. 2007;9:2181–2191. doi:10.1111/j.1462-5822.2007.00948.x.
   PubMed Web of Science ®Google Scholar
• Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest. 2005;115:1806–1815. doi:10.1172/JCI23865.
   PubMed Web of Science ®Google Scholar
• Matak P, Heinis M, Mathieu JR, Corriden R, Cuvellier S, Delga S, Mounier R, Rouquette A, Raymond J, Lamarque D, et al. Myeloid HIF-1 is protective in Helicobacter pylori-mediated gastritis. J Immunol. 2015;194:3259–3266. doi:10.4049/jimmunol.1401260.
   PubMed Web of Science ®Google Scholar
• Zhu X, Jiang L, Wei X, Long M, Du Y. Roxadustat: not just for anemia. Front Pharmacol. 2022;13:971795. doi:10.3389/fphar.2022.971795.
   PubMed Web of Science ®Google Scholar
• Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Dockray GJ. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest. 1996;98(8):1918–1929. doi:10.1172/JCI118993.
   PubMed Web of Science ®Google Scholar
• Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterol. 2000;118(1):36–47. doi:10.1016/S0016-5085(00)70412-4.
   PubMed Web of Science ®Google Scholar
• Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N, Dangler CA, Israel DA, Krishna U, Gaus K, et al. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterol. 2003;124(7):1879–1890. doi:10.1016/S0016-5085(03)00406-2.
   PubMed Web of Science ®Google Scholar
• Noto JM, Rose KL, Hachey AJ, Delgado AG, Romero-Gallo J, Wroblewski LE, Schneider BG, Shah SC, Cover TL, Wilson KT, et al. Carcinogenic Helicobacter pylori strains selectively dysregulate the in vivo gastric proteome, which may be associated with stomach cancer progression. Molecular & Cellular Proteomics: MCP. 2019;18(2):352–371. doi:10.1074/mcp.RA118.001181.
   PubMed Web of Science ®Google Scholar